$53.55
0.51% today
NYSE, Sep 04, 07:15 pm CET

Haemonetics Corporation Stock price

$53.28
-23.02 30.17% 1M
-11.80 18.13% 6M
-24.80 31.76% YTD
-21.79 29.03% 1Y
-20.46 27.75% 3Y
-36.78 40.84% 5Y
+17.29 48.04% 10Y
+31.16 140.81% 20Y
NYSE, Closing price Wed, Sep 03 2025
-0.26 0.49%

Key metrics

Basic
Market capitalization
$2.6b
Enterprise Value
$3.5b
Net debt
$931.9m
Cash
$292.9m
Shares outstanding
48.2m
Valuation (TTM | estimate)
P/E
15.8 | 10.9
P/S
1.9 | 2.0
EV/Sales
2.6 | 2.7
EV/FCF
21.8
P/B
2.9
Financial Health
Equity Ratio
33.5%
Return on Equity
20.4%
ROCE
12.6%
ROIC
9.6%
Debt/Equity
1.4
Financials (TTM | estimate)
Revenue
$1.3b | $1.3b
EBITDA
$291.0m | $441.2m
EBIT
$243.8m | $342.2m
Net Income
$163.3m | $234.7m
Free Cash Flow
$160.8m
Growth (TTM | estimate)
Revenue
0.9% | -3.9%
EBITDA
19.9% | 50.3%
EBIT
18.5% | 39.5%
Net Income
42.2% | 40.0%
Free Cash Flow
133.8%
Margin (TTM | estimate)
Gross
57.4%
EBITDA
21.6% | 33.7%
EBIT
18.1%
Net
12.1% | 17.9%
Free Cash Flow
12.0%
More
EPS
$3.4
FCF per Share
$3.3
Short interest
12.1%
Employees
4k
Rev per Employee
$370.0k
Show more

Is Haemonetics Corporation a Top Scorer Stock based on the Dividend, High-Growth-Investing or Leverman Strategy?

As a Free StocksGuide user, you can view scores for all 7,003 stocks worldwide.

Haemonetics Corporation Stock Analysis

Unlock Scores for Free

Analyst Opinions

15 Analysts have issued a Haemonetics Corporation forecast:

12x Buy
80%
2x Hold
13%
1x Sell
7%

Analyst Opinions

15 Analysts have issued a Haemonetics Corporation forecast:

Buy
80%
Hold
13%
Sell
7%

Financial data from Haemonetics Corporation

Income Statement P&L | Balance Sheet | Cash Flow


Quarter TTM Annually
Jun '25
+/-
%
1,346 1,346
1% 1%
100%
- Direct Costs 573 573
7% 7%
43%
773 773
8% 8%
57%
- Selling and Administrative Expenses 415 415
0% 0%
31%
- Research and Development Expense 65 65
16% 16%
5%
291 291
20% 20%
22%
- Depreciation and Amortization 47 47
27% 27%
4%
EBIT (Operating Income) EBIT 244 244
19% 19%
18%
Net Profit 163 163
42% 42%
12%

In millions USD.

Don't miss a Thing! We will send you all news about Haemonetics Corporation directly to your mailbox free of charge.

If you wish, we will send you an e-mail every morning with news on stocks of your portfolios.

Haemonetics Corporation Stock News

Positive
Seeking Alpha
24 days ago
Haemonetics Corporation remains a high-quality blood-management franchise with strong TEG and plasma software moats, but recent growth has paused due to portfolio shifts and competition. Q1 FY2026 results beat expectations on margins and cash flow, but headline revenue declined due to deliberate exits and one-time factors boosting growth. HAE valuation is compelling at ~11x forward EPS and ~8x ...
Neutral
Seeking Alpha
26 days ago
Haemonetics Corporation (NYSE:HAE ) Q1 2026 Earnings Conference Call August 7, 2025 8:00 AM ET Company Participants Christopher A. Simon - CEO, President & Director James C.
Neutral
The Motley Fool
28 days ago
Haemonetics (HAE) Q1 Revenue Falls 4%
More Haemonetics Corporation News

Company Profile

Haemonetics Corp. engages in the development and distribution of hematology products and solutions. It operates through the following geographical segments: Japan, EMEA (Europe, the Middle East, and Africa), North America Plasma, and All Other. Its products include surgical and diagnostic devices, blood and plasma center devices, blood center software, hospital software, and plasma center software. The company was founded by Allen Latham, Jr. in 1971 and is headquartered in Braintree, MA.

Head office United States
CEO Christopher Simon
Employees 3,657
Founded 1971
Website www.haemonetics.com

Register for Free

StocksGuide is the ultimate tool for easily finding, analyzing and tracking stocks. Learn from successful investors and make informed investment decisions. We empower you to become a confident, independent investor.

The Apple stock at a glance with charts, current key metrics, news and stock analyses.
The Best Dividend Stocks in the Dividend Top Scorer list.
Stock Analyses of the Best Stocks Worldwide.
Start building wealth today